DiaMedica Therapeutics Inc.
Clinical trials sponsored by DiaMedica Therapeutics Inc., explained in plain language.
A clinical-stage biopharmaceutical company developing treatments for kidney and neurological diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New stroke drug aims to help patients missed by standard treatments Results expected Dec 2026 (estimated) š Make-or-break